Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003073-27Phase 3Completed
Phase 3 trial of clobetasol in psoriasis (4 arms), sponsored by Galderma. Primary endpoint: Subjects' overall preference at end of treatment period II. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003073-27.